medigraphic.com
ISSN 1561-302X (Print)

2013, Number 1

<< Back Next >>

Rev cubana med 2013; 52 (1)

Lance Adams Syndrome

Ruiz GD, Olivera LI, Gómez VN

Language: Spanish
References: 16
Page: 72-77
PDF size: 147.13 Kb.


ABSTRACT

The chronic poshipoxia myoclonus or Lance Adams syndrome is a rare complication that occurs in patients who survive prolonged hypoxia or hypotension, days or weeks after the complication. A case with this syndrome, hypovolemic shock secondary to a ruptured ectopic pregnancy is presented. EEG with no paroxysms supports the origin of myoclonus subcortical with favorable response to alonazepán. Neuroimaging and auditory evoked potentials and brainstem studies were detailed.


REFERENCES

  1. Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet Neurol. 2004;3:598-607.

  2. Lance JW, Adams RD. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain. 1963;86(1):111-36.

  3. Welsh JP, Placantonakis DG, Warsetsky SI, Marquez RG, Bernstein L, Aicher SA. The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity. Adv Neurol. 2002;89(1):307-29.

  4. Richardson JC, De Léan J, Hornykiewicz O. Beneficial effects of serotonin precursors in postanoxic action myoclonus.Neurology. 1976;26(9):863-8.

  5. Lhermitte F, Talairach J, Buser P. Myoclonies d'intention et d'action postanoxiques: Etude stereotaxique et destruction du noyau central lateral du thalamus. Rev Neurol. 1971;124:1-20.

  6. Welsh JP, Yuen G, Placantonakis DG, Vu TQ, Haiss F, O'Hearn E, et al. Why do Purkinje cells die so easily after global brain ischemia? Aldolase C, EAAT4, and the cerebellar contribution to posthypoxic myoclonus. Adv Neurol. 2002;89(2):331-59.

  7. Yan-xing Zhang, Jian-ren Liu, Biao Jiang, Hui-qin Liu, Mei-ping Ding,Shui-jiang Song, et al. Lance-Adams syndrome: a report of two cases. Journal of Zhejiang University Science. 2007;8(10):11-13.

  8. Dubinsky RM, Hallett M, Di Chiro G, Fulham M, Schwankhaus J. Increased glucose metabolism in the medulla of patients with palatal myoclonus. Neurology. 1991;41(4):557-62.

  9. Frucht SJ, Trost M, Ma Y, Eidelberg D. The metabolic topography of posthypoxic myoclonus. Neurology. 2004;62(10):1879-81.

  10. Frucht SJ, Fahn S. The clinical spectrum of posthypoxic myoclonus. Mov Disord. 2000;15 (Suppl 1):2-7.

  11. Frucht SJ, Louis ED, Chuang C, Fahn S. A pilot tolerability and efficacy study of Levetiracetam in patients with chronic myoclonus. Neurology. 2001;57(6):111-24.

  12. Krauss GL, Bergin A, Kramer RE, Cho YW, Reich SG. Suppression of post-hypoxic and post-encephalitic myoclonus with Levetiracetam. Neurology. 2001;56(3):411-2.

  13. Lim LL, Ahmed A. Limited efficacy of Levetiracetam on myoclonus of different etiologies. Parkinsonism Relat Disord. 2005;11(2):135-7.

  14. Guo XH, Yu SY, Liu J, Wu WP, Pu CQ, Zhu K. Posthypoxic myoclonus treated with 5-hydroxytryptophan: a case report. J Clin Neurol. 2002;15(5):313.

  15. Arpesella R, Dallocchio C, Arbasino C, Imberti R, Martinotti R, Frucht SJ. A patient with intractable posthypoxic myoclonus (Lance-Adams syndrome) treated with sodium oxybate. Anaesth Intens Care. 2009;1(1):1-2.

  16. Werhahn KJ, Brown P, Thompson PD, Marsden CD. The clinical features and prognosis of chronic posthypoxic myoclonus. Mov Disord. 1997;12(2):216-20.




2020     |     www.medigraphic.com